Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |